Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
92,315,749
-
Total 13F shares
-
103,820,203
-
Share change
-
-6,077,916
-
Total reported value
-
$4,245,471,937
-
Put/Call ratio
-
36%
-
Price per share
-
$40.91
-
Number of holders
-
246
-
Value change
-
-$240,483,248
-
Number of buys
-
123
-
Number of sells
-
98
Institutional Holders of Acadia Healthcare Company, Inc. - Common Stock, par value $0.01 per share (ACHC) as of Q2 2018
As of 30 Jun 2018,
Acadia Healthcare Company, Inc. - Common Stock, par value $0.01 per share (ACHC) was held by
246 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
103,820,203 shares.
The largest 10 holders included
PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, Aristotle Capital Management, LLC, JPMORGAN CHASE & CO, DIMENSIONAL FUND ADVISORS LP, Invesco Ltd., GOLDMAN SACHS GROUP INC, and P2 Capital Partners, LLC.
This page lists
246
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.